Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.
Identifieur interne : 000132 ( Ncbi/Curation ); précédent : 000131; suivant : 000133Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.
Auteurs : J J Ferreira [France] ; O. RascolSource :
- Current opinion in neurology [ 1350-7540 ] ; 2000.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- drug therapy : Movement Disorders, Parkinson Disease.
- prevention & control : Movement Disorders.
- surgery : Movement Disorders.
- therapy : Movement Disorders.
- Humans.
Abstract
Levodopa-induced dyskinesias represent a major shortcoming of Parkinson's disease management, and its pharmacological treatment is generally unsatisfactory. However, the conclusive demonstration of the benefits associated with early prescription of a dopamine agonist, the antidyskinetic properties of 'old' antiparkinsonian compounds such as amantadine, and the striking results of functional stereotatic neurosurgery are extremely important advances for the treatment of levodopa-induced dyskinesias.
PubMed: 10970061
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001305
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001264
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001264
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000132
Links to Exploration step
pubmed:10970061Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.</title>
<author><name sortKey="Ferreira, J J" sort="Ferreira, J J" uniqKey="Ferreira J" first="J J" last="Ferreira">J J Ferreira</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Investigation Centre, University Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Investigation Centre, University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10970061</idno>
<idno type="pmid">10970061</idno>
<idno type="wicri:Area/PubMed/Corpus">001305</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001305</idno>
<idno type="wicri:Area/PubMed/Curation">001264</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001264</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001264</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001264</idno>
<idno type="wicri:Area/Ncbi/Merge">000132</idno>
<idno type="wicri:Area/Ncbi/Curation">000132</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.</title>
<author><name sortKey="Ferreira, J J" sort="Ferreira, J J" uniqKey="Ferreira J" first="J J" last="Ferreira">J J Ferreira</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Investigation Centre, University Hospital, Toulouse, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Investigation Centre, University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
</author>
</analytic>
<series><title level="j">Current opinion in neurology</title>
<idno type="ISSN">1350-7540</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term>
<term>Humans</term>
<term>Levodopa (adverse effects)</term>
<term>Movement Disorders (drug therapy)</term>
<term>Movement Disorders (prevention & control)</term>
<term>Movement Disorders (surgery)</term>
<term>Movement Disorders (therapy)</term>
<term>Parkinson Disease (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Levodopa-induced dyskinesias represent a major shortcoming of Parkinson's disease management, and its pharmacological treatment is generally unsatisfactory. However, the conclusive demonstration of the benefits associated with early prescription of a dopamine agonist, the antidyskinetic properties of 'old' antiparkinsonian compounds such as amantadine, and the striking results of functional stereotatic neurosurgery are extremely important advances for the treatment of levodopa-induced dyskinesias.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000132 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000132 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:10970061 |texte= Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:10970061" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |